Search Menu
Photonics Media Photonics Buyers' Guide Photonics EDU Photonics Spectra BioPhotonics EuroPhotonics Industrial Photonics Photonics Showcase Photonics ProdSpec Photonics Handbook
More News
Email Facebook Twitter Google+ LinkedIn Comments

MorphoSys Strengthens European Patent Position

Photonics Spectra
May 2009
MorphoSys AG of Martinsried/Munich, Germany, a biotechnology company that generates fully human antibodies, has been granted a divisional patent from the European Patent Office stemming from its base HuCAL (Human Combinatorial Antibody Library) patent family. The patent, EP1143006, will capture HuCAL’s modular design at the DNA level to provide solid product claim protection in Europe. The library comprises highly diverse, fully human synthetic antibodies that are engineerable through their modular CDR (clock and data recovery) design.

biotechnologyDNAMorphoSys AGPatent NewsSlices from the Breadboard

Terms & Conditions Privacy Policy About Us Contact Us
back to top

Facebook Twitter Instagram LinkedIn YouTube RSS
©2018 Photonics Media
x Subscribe to Photonics Spectra magazine - FREE!